Cargando…

DELAYED TREATMENT EFFECTS OF XANTHINE OXIDASE INHIBITION ON SYSTOLIC OVERLOAD-INDUCED LEFT VENTRICULAR HYPERTROPHY AND DYSFUNCTION

The nonpurine selective xanthine oxidase (XO) inhibitor febuxostat attenuates development of left ventricular (LV) hypertrophy and dysfunction in mice when treatment is initiated within 1 hour of transverse aortic constriction (TAC). This study investigated whether a 7-day delay of treatment with th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, X., Zhao, L., Hu, X., Zhang, P., Wessale, J., Bache, R., Chen, Y.
Formato:	Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903770/ https://www.ncbi.nlm.nih.gov/pubmed/20544512 http://dx.doi.org/10.1080/15257771003738683

Ejemplares similares

Interstitial expansion in pressure overload left ventricular hypertrophy
por: Treibel, Thomas A, et al.
Publicado: (2013)

Platelet volume indices are associated with systolic and diastolic cardiac dysfunction, and left ventricular hypertrophy
por: Fujita, Shu-ichi, et al.
Publicado: (2015)

The major factor of left ventricular systolic dysfunction in patients with cardiac amyloidosis: Amyloid overload or microcirculation impairment?
por: Lu, Jianyao, et al.
Publicado: (2023)

Hyperglycemia and nocturnal systolic blood pressure are associatedwith left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients
por: Felício, João S, et al.
Publicado: (2006)

Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca(2+) Handling After Pressure Overload
por: Bartoli, Fiona, et al.
Publicado: (2020)

2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy
por: Maayah, Zaid H., et al.
Publicado: (2018)

Association of Interarm Systolic Blood Pressure Difference with Atherosclerosis and Left Ventricular Hypertrophy
por: Su, Ho-Ming, et al.
Publicado: (2012)

Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation
por: Salvador, Ane M., et al.
Publicado: (2017)

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
por: Fujimura, Yuki, et al.
Publicado: (2017)

Reversible Left Ventricular Systolic Dysfunction Secondary to Pazopanib
por: Gajjar, Kushani, et al.
Publicado: (2018)

Autoimmune myocarditis is not associated with left ventricular systolic dysfunction
por: Mirna, Moritz, et al.
Publicado: (2019)

Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction
por: Schlegel, Todd T, et al.
Publicado: (2010)

Xanthine oxidase inhibitors and sepsis
por: Ramos, Maria Fátima de Paula, et al.
Publicado: (2018)

Inhibition of Xanthine Oxidase-Catalyzed Xanthine and 6-Mercaptopurine Oxidation by Flavonoid Aglycones and Some of Their Conjugates
por: Mohos, Violetta, et al.
Publicado: (2020)

Non-invasive assessment of interstitial myocardial fibrosis in pressure-overload left ventricular hypertrophy
por: Jabbour, Andrew, et al.
Publicado: (2012)

Left Ventricular Systolic Function Assessed by Speckle Tracking Echocardiography in Athletes with and without Left Ventricle Hypertrophy
por: Żebrowska, Aleksandra, et al.
Publicado: (2019)

Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction
por: Docherty, Kieran F., et al.
Publicado: (2021)

Heart rate variability as an indicator of left ventricular systolic dysfunction
por: Shehab, Abdulla, et al.
Publicado: (2009)

Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target?
por: Margonato, Davide, et al.
Publicado: (2021)

Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction
por: Yagi, Nobuichiro, et al.
Publicado: (2021)

Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
por: Nomura, Johji, et al.
Publicado: (2014)

Cinaciguat prevents the development of pathologic hypertrophy in a rat model of left ventricular pressure overload
por: Németh, Balázs Tamás, et al.
Publicado: (2016)

Dysregulation of proangiogeneic factors in pressure-overload left-ventricular hypertrophy results in inadequate capillary growth
por: Zeriouh, Mohamed, et al.
Publicado: (2019)

Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients
por: Romejko, Katarzyna, et al.
Publicado: (2022)

XANTHINE OXIDASE ACTIVITY IN REGENERATING LIVER
por: Feigelson, Muriel, et al.
Publicado: (1957)

Study of Drug Metabolism by Xanthine Oxidase
por: Zhao, Jing, et al.
Publicado: (2012)

Xanthine Oxidase—A Personal History
por: Hille, Russ
Publicado: (2023)

Estimated Glomerular Filtration Rate and Systolic Time Intervals in Risk Stratification for Increased Left Ventricular Mass Index and Left Ventricular Hypertrophy
por: Lee, Wen-Hsien, et al.
Publicado: (2016)

NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload
por: Schnelle, Moritz, et al.
Publicado: (2019)

Xanthine oxidase and aldehyde oxidase contribute to allopurinol metabolism in rats
por: Tayama, Yoshitaka, et al.
Publicado: (2022)

Association of Arterial Stiffness and Electrocardiography-Determined Left Ventricular Hypertrophy with Left Ventricular Diastolic Dysfunction
por: Hsu, Po-Chao, et al.
Publicado: (2012)

Echocardiographic assessment of inappropriate left ventricular mass and left ventricular hypertrophy in patients with diastolic dysfunction
por: Shemirani, Hasan, et al.
Publicado: (2012)

The Correlation Between Left Ventricular Failure and Right Ventricular Systolic Dysfunction Occurring in Thyrotoxicosis
por: Hong, Ji Yeon, et al.
Publicado: (2010)

Upregulation of Soluble HLA-G in Chronic Left Ventricular Systolic Dysfunction
por: Olesen, Line Lisbeth, et al.
Publicado: (2016)

Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction
por: Wang, Li, et al.
Publicado: (2019)

Angina due to coronary artery disease with left ventricular systolic dysfunction
por: Lopatin, Yury
Publicado: (2019)

Left Atrial Contractility in Ischemic Heart Disease Patients with Left Ventricular Systolic Dysfunction
por: El Missiri, Ahmed, et al.
Publicado: (2016)

Mitral annular plane systolic excursion for assessing left ventricular systolic dysfunction in patients with septic shock
por: Brault, Clément, et al.
Publicado: (2023)

The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease
por: Higgins, Peter, et al.
Publicado: (2009)

Central systolic blood pressure and central pulse pressure predict left ventricular hypertrophy in hypertensive children
por: Litwin, Mieczysław, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_15brqi7le5p3c2cl5idlr1mtnk